27 results on '"Miles, L."'
Search Results
2. PSS42 - SECUKINUMAB SIGNIFICANTLY REDUCES PSORIASIS-RELATED WORK IMPAIRMENT AND INDIRECT COSTS COMPARED TO USTEKINUMAB AND ETANERCEPT IN MOROCCO
3. PIH54 - A GLOBAL REVIEW OF QUALITY OF LIFE IMPACT OF ATOPIC DERMATITIS IN CHILDREN
4. PSS41 - SECUKINUMAB SIGNIFICANTLY REDUCES PSORIASIS-RELATED WORK IMPAIRMENT AND INDIRECT COSTS COMPARED TO USTEKINUMAB AND ETANERCEPT IN TUNISIA
5. Cost-Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
6. Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
7. Secukinumab Significantly Reduces Work Impairment and Indirect Costs Compared To Ustekinumab and Etanercept In The United Kingdom
8. Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective
9. Budget Impact of Secukinumab For Ankylosing Spondylitis In The UK
10. A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING PSORIATIC ARTHRITIS TREATMENTS
11. A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING ANKYLOSING SPONDYLITIS TREATMENTS
12. Estimation of Indirect (Work-Related Productivity) Costs Associated With Moderate-To-Severe Plaque Psoriasis In Germany
13. A New Cost-Effectiveness Framework For Modeling Psoriasis Treatments
14. PSS22 - Secukinumab Significantly Reduces Work Impairment and Indirect Costs Compared To Ustekinumab and Etanercept In The United Kingdom
15. PMS54 - Cost-Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
16. PMS43 - Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective
17. PMS44 - Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
18. PMS28 - Budget Impact of Secukinumab For Ankylosing Spondylitis In The UK
19. PMS52 - A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING ANKYLOSING SPONDYLITIS TREATMENTS
20. PMS51 - A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING PSORIATIC ARTHRITIS TREATMENTS
21. A novel approach to ranking parameter uncertainty in one-way sensitivity analysis: What tornado diagrams are missing
22. PRM60 - A New Cost-Effectiveness Framework For Modeling Psoriasis Treatments
23. RM41 - A novel approach to ranking parameter uncertainty in one-way sensitivity analysis: What tornado diagrams are missing
24. PSS23 - Estimation of Indirect (Work-Related Productivity) Costs Associated With Moderate-To-Severe Plaque Psoriasis In Germany
25. PSS23 Estimation of Indirect (Work-Related Productivity) Costs Associated With Moderate-To-Severe Plaque Psoriasis In Germany
26. RM41 A novel approach to ranking parameter uncertainty in one-way sensitivity analysis: What tornado diagrams are missing
27. PRM60 A New Cost-Effectiveness Framework For Modeling Psoriasis Treatments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.